KDM3A and congestive heart failure: In this study, it was demonstrated that KDM3A was ablated in the myocardium of CHF mice; the augmented KDM3A contributed to mitigating the cardiac function injury, oxidative stress, pathological change, inflammatory responses and the cardiomyocyte apoptosis in CHF mice.